Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases

Mitchell, J., Camacho, N., Shea, P., Stopsack, K. H., Joseph, V., Burren, O. S., Dhindsa, R. S., Nag, A., Berchuck, J. E., O’Neill, A., Abbasi, A., Zoghbi, A. W., Alegre-Díaz, J., Kuri-Morales, P., Berumen, J., Tapia-Conyer, R., Emberson, J., Torres, J. M., Collins, R., … Fabre, M. A. (2025). Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-56944-1
Authors:
Jonathan Mitchell
Niedzica Camacho
Patrick Shea
Konrad H Stopsack
Vijai Joseph
Oliver S Burren
Ryan S Dhindsa
Abhishek Nag
Jacob E Berchuck
Amanda O'Neill
Ali Abbasi
Anthony W Zoghbi
Jesus Alegre-Díaz
Pablo Kuri-Morales
Jaime Berumen
Roberto Tapia-Conyer
Jonathan Emberson
Jason M Torres
Rory Collins
Quanli Wang
David Goldstein
Athena Matakidou
Carolina Haefliger
Lauren Anderson-Dring
Ruth March
Vaidehi Jobanputra
Brian Dougherty
Keren Carss
Slavé Petrovski
Philip W Kantoff
Kenneth Offit
Lorelei A Mucci
Mark Pomerantz
Margarete A Fabre
Affiliated Authors:
Patrick Shea
David Goldstein
Vaidehi Jobanputra
Columbia Affiliation:
Subjects:
Prostatic Neoplasms (MeSH)
Germ-Line Mutation (MeSH)
Checkpoint Kinase 2 (MeSH)
Genetic Predisposition to Disease (MeSH)
Ataxia Telangiectasia Mutated Proteins (MeSH)
BRCA2 Protein (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1038/s41467-025-56944-1
PMID:
39971927
DOI:
10.1038/s41467-025-56944-1
Journal:
Nature Communications
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: